Targeting hepatic glucokinase in type 2 diabetes: weighing the benefits and risks.

ABSTRACT:

SUBMITTER: Agius L 

PROVIDER: S-EPMC2606869 | biostudies-literature | 2009 Jan

REPOSITORIES: biostudies-literature